Skip to main content
. 2004 Sep 30;4:28. doi: 10.1186/1471-244X-4-28

Table 2.

Mean (± SD) SKAMP Total Scores at Each Observation Session for Each Treatment at Each Dose Levela

MCD CON PLA
Observation Session (hrs) Low Med High Low Med High Low Med High
0 18.48 (11.82) 20.88 (12.95) 19.91 (13.15) 18.04 (10.13) 19.14 (12.14) 21.47 (13.06) 13.58 (9.72) 16.02 (11.84) 13.96 (11.14)
1.5 11.44 (7.99) 10.98 (8.62) 6.55 (5.85) 14.04 (9.85) 14.86 (12.01) 11.34 (9.71) 19.10 (12.83) 19.47 (12.56) 18.88 (13.48)
3.0 12.57 (9.92) 11.03 (9.66) 7.31 (6.10) 16.44 (12.43) 15.29 (12.72) 12.62 (11.00) 21.47 (14.61) 20.98 (14.11) 22.11 (14.10)
4.5 13.46 (11.53) 12.39 (10.32) 9.15 (8.62) 17.55 (13.37) 15.09 (12.60) 13.55 (11.91) 20.23 (11.92) 22.09 (15.46) 23.44 (12.55)
6.0 16.08 (13.27) 14.47 (11.53) 10.30 (9.71) 17.00 (12.12) 14.28 (11.73) 12.04 (11.62) 22.98 (12.79) 22.15 (13.91) 26.02 (14.56)
7.5 15.85 (11.21) 17.26 (13.63) 14.29 (12.55) 18.62 (12.66) 15.19 (13.47) 13.47 (12.97) 23.54 (12.96) 23.13 (14.72) 24.48 (14.68)
12.0 20.44 (13.75) 20.28 (15.02 19.85 (14.41) 16.90 (13.36) 17.81 (13.84) 16.74 (14.98) 19.45 (13.46) 20.73 (13.46) 22.02 (15.17)

aLower SKAMP scores indicate greater efficacy

CON = Concerta; MCD = Metadate CD; PLA = placebo. Low = Low Dose (CON 18 mg; MCD 20 mg), Med = Medium Dose (CON 36 mg; MCD 40 mg), Hi = High Dose (CON 54 mg ; MCD 60 mg).